| Name | Title | Contact Details |
|---|---|---|
Gad Sakin |
CTO | Profile |
Angela Lim |
Deputy General Counsel | Profile |
Promex, located in Silicon Valley, is an ISO 13485:2003 Medical and ISO 9001:2008 certified microelectronics, semiconductor & advanced packaging and high reliability SMT/PCBA contract assembly service provider for the medical & bioscience, commercial and military markets. Core competencies allow the sequential steps of prototypes, new product introductions & beta production, followed by volume manufacturing. Complete in-house microelectronics process capabilities and process expertise uniquely integrates SMT / PCBA with microelectronics assembly. Facilities include Class 100 and Class 1000 clean rooms, RoHS optimized SMT/PCBA lines, plus development & assembly areas. ISO 13485 Medical process verification and validation using IQ, OQ, PQ and pFMEA practices and extensive use of statistical process controls. Complete Microelectronics Assembly Process Flows: • Wafer handling and sawing including 300 mm wafers • Fully automatic die attach • Wire bonding (Au ball, Al wedge, RF ribbon & wedge, Cu) • Plastic over molding (multi-chip modules, arrays, system-in-package) • Precision materials dispense • Encapsulation • Flip Chip High Reliability SMT/PCBA and Chip-on-Substrate: RoHS optimized SMT lines allow single facility process integration. Leaded solder processing also available. Chip-on-Substrate expertise. IPC-A-610 Class 3 assembly. Consigned and full turnkey SMT/PCBA and supply chain management. Quality Systems (Medical): FDA Title 21 Part 820 compliance ensures device history files, operator training records, IQ, OQ, PQ and process documentation meet all standards.
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. With more than three decades of expertise in all areas of oncology practice management, AON enables physicians to focus on what matters most – providing the highest quality care for patients. We preserve and protect the sustainability of community oncology for physicians, patients and partners, so practices thrive. Ensure that every American has local access to exceptional cancer care. AON provides comprehensive administrative support and ancillary services that help community oncology practices thrive in an increasingly complex healthcare environment. Our collaborative approach and physician-led model allows practices to maintain local leadership and autonomy. With over three decades of successfully improving and advancing community oncology practices, we have developed a proven business model that allows practices to benefit from our scale and expertise in such critical areas as drug-procurement and payer contracting, as well as practice diversification through central lab and pathology, specialty pharmacy. AON was created and is led by the leadership team responsible for the success of Florida Cancer Specialists & Research Institute, the nation`s largest independent community oncology practice. Our team has vast experience in complex and diverse group practice integration and is able to ensure a smooth and successful transition process for local practices that choose to become a part of the AON.
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.
Electromedical Products International Inc is a Mineral Wells, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.